RU
Address
220006, Minsk, Leningradskaya Str. 6, office 2
Tel.: +375 17 363-88-92
E-mail: medjournal@bsmu.by

Сложности дифференциальной диагностики врождённого ангионевротического отёка

И.Е. Гурьянова, Е.А. Полякова, Ю.С. Жаранкова, М.В. Белевцев Республиканский научно-практический центр детской онкологии, гематологии и иммунологии, Минск
2019 №2 | Лекции
Аннотация
Список литературы
Скачать полнотекстовую статью
Рецидивирующие ангионевротические отёки представляют собой важную клиническую проблему, актуальность которой обусловлена не только недостаточными сведениями о механизмах развития, но и серьёзным влиянием недуга на все стороны жизни пациентов, сложностями диагностики и лечения. Важно отличать врождённые ангионевротические отёки от приобретённых, т.к. механизмы развития и участвующих компонентов иммунной системы у них различаются, поэтому так же различаются и препараты, которые будут эффективными для купирования отёка.
Ключевые слова:
ангионевротический отёк, врождённый ангионевротический отёк, брадикинин, хроническая крапивница, синдром системной капиллярной проницаемости
Difficulties of differential diagnosis of hereditary angioedema

Recurrent angioedema is a complex problem, the relevance of which depends not only on access to information. It is very important to distinguish hereditary angioedema from acquired, because they are different in development and immune mechanisms, therefore, the treatment that will be effective for the relief of edema also differ.

Keywords
angioedema, hereditary angioedema, bradykinin, epical chronical urticaria, capillary leak syndrome
  • 1. Amar SM, Dreskin SC. Urticaria. Primary Care: Clinics in Office Practice 2008, 35: 141-157.
  • 2. Amoura Z, Papo T, Ninet J, Hatron PY, Guillaumie J, Piette AM, Blétry O, Dequiedt P, Talasczka A, Rondeau E, Dutel JL, Wechsler B, Piette JC. Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med. 1997, 103: 514-519.
  • 3. Bafunno V, Divella C, Sessa F, Tiscia GL, Castellano G, Gesualdo L et al. De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema. J Allergy ClinImmunol 2013, 132:748-750.
  • 4. Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicardi M. Long–term follow–up of 111 patients with angiotensinconverting enzyme inhibitor–related angioedema. J Hypertens 2011, 29: 2273-2277.
  • 5. Blanch A, Roche O, Urrutia I, Gamboa P, Fontan G, Lopez–Trascasa M. First case of homozygous C1 inhibitor deficiency. J Allergy ClinImmunol 2006, 118: 1330-1335.
  • 6. Bork K, Gul D, Hardt J, Dewald G. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. Am J Med 2007, 120: 987-992.
  • 7. Bork K, Witzke G. Long–term prophylaxis with C1–inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1–inhibitor deficiency. J Allergy ClinImmunol 1989, 83: 677-682.
  • 8. Bork K, Wulff K, Witzke G, Hardt J. Hereditary angioedema with normal C1–INH with versus without specific F12 gene mutations. Allergy 2015; 70: 1004-1012.
  • 9. Bowen T., Cicardi M., Farkas H., Bork K. et al. Canadian 2003 international consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Journal of Allergy and Clinical Immunology 2004; 114: 629–637.
  • 10. Byrd JB, Adam A, Brown NJ. Angiotensinconverting enzyme inhibitor–associated angioedema. Immunol Allergy Clin North Am 2006, 26: 725-737.
  • 11. Cicardi M, Bergamaschini L, Zingale LC, Gioffre D, Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med 1999, 106: 650-654.
  • 12. Cicardi M, Zanichelli A. The acquired deficiency of C1–inhibitor: lymphoproliferation and angioedema. CurrMol Med 2010, 10: 354-360.
  • 13. Cicardi M., Aberer W., Banerji A., Bas M., Bernstein J.A., Bork K., Caballero T., Farkas H., Grumach A., Kaplan A.P., Riedl M.A., Triggiani M., Zanichelli A., Zuraw B.. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014 May, 69(5): 602-16.
  • 14. Colas C, Montoiro R, Fraj J, Garces M, Cubero JL, Caballero T. Nonhistaminergic idiopathic angioedema: clinical response to icatibant. J InvestigAllergolClinImmunol 2012, 22: 520-521.
  • 15. Craig Т., Aygӧren Parsun Е., Bork К., [et al.]. WAO guideline for the management of hereditary angioedema. World Allergy Organ J. 2012 Dec, 5(12): 182-199.
  • 16. Cupido C, Rayner B. Life–threatening angio–oedema and death associated with the ACE inhibitor enalapril. S Afr Med J 2007, 97: 244-245.
  • 17. Del Corso I, Puxeddu I, Sardano E, Geraci S, Breggia M, Rocchi V et al. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant. Ann Allergy Asthma Immunol 2012, 108: 460-461.
  • 18. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C1–esterase. Am J Sci 1963, 31: 37-44.
  • 19. Dreyfus DH, Schocket AL, Milgrom H. Steroid–resistant chronic urticaria associated with anti–thyroid microsomal antibodies in a nine–year–old boy. J Pediatr. 1996 Apr, 128(4): 576-8.
  • 20. Druey KM, Parikh SM. Idiopathic systemic capillary leak syndrome (Clarkson disease). J AllergyClinImmunol. December 22, 2016.
  • 21. Farkas H. Current pharmacotherapy of bradykinin–mediated angioedema. Expert OpinPharmacother 2013, 14: 571-586.
  • 22. Fraser K, Robertson L. Chronic urticaria and autoimmunity. SkinTherapyLett. 2013, 18(7): 5-9.
  • 23. Gianni P. International Archives of Allergy and Immu–nology. 2017,. 174(3-4): 200-204.
  • 24. Joseph K, Tholanikunnel BG, Wolf B, et al. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. J Allergy ClinImmunol 2016, 137: 1822-1829.
  • 25. Kaplan, A.P., Greaves M.W., Angioedema. J Am AcadDermatol, 2005., 53(3): 373-388; quiz 389-392.
  • 26. Kapoor P., Greipp P., Schaefer E.W. [et al.]. Idiopathic Systemic Capillary Leak Syndrome (Clarkson's Disease): The Mayo Clinic Experience. MayoClinProc. 2010 Oct, 85(10): 905-912.
  • 27. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005, 165: 1637-1642.
  • 28. Lin RY, Cannon AG, Teitel AD. Pattern of hospitalizations for angioedema in New York between 1990 and 2003. Ann Allergy Asthma Immunol 2005, 95: 159-166.
  • 29. Longhurst HJ, Farkas H, Craig T, Aygoren–Pursun E, Bethune C, Bjorkander J et al. HAE international home therapy consensus document. Allergy Asthma ClinImmunol 2010, 6: 22.
  • 30. Lopez–Lera A, Favier B, de la Cruz RM, Garrido S, Drouet C, Lopez–Trascasa M. A new case of homozygous C1–inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation. J Allergy ClinImmunol 2010, 126: 1307-1310.
  • 31. Madsen F, Attermann J, Linneberg A. Epidemiology of non–hereditary angioedema. ActaDermVenereol. 2012, 92: 449-581.
  • 32. Montinaro V, Loizzo G, Zito A, Castellano G, Gesualdo L. Successful treatment of a facial attack of angioedema with icatibant in a patient with idiopathic angioedema. Am J Emerg Med 2013, 31: 1295.
  • 33. Piñero–Saavedra M, Teresa González–Quevedo T. J. The genetics of hereditary angioedema: A review. Rare Dis Res Treat. 2017, 2(4): 14-19.
  • 34. Rye Rasmussen EH, Bindslev–Jensen C, Bygum A. Angioedema–assessment and treatment. Tidsskr Nor Laegeforen 2012, 132: 2391-2395.
  • 35. Subothini S. S., Aggarwal N. Chronic urticaria and thyroid autoimmunity: a perplexing association. Oxf Med Case Reports. 2018 Feb; 2018, 2: 99.
  • 36. Tedeschi A, Asero R, Lorini M, Marzano AV, Cugno M. Different rates of autoreactivity in patients with recurrent idiopathic angioedema associated or not with wheals. J InvestigAllergolClinImmunol 2012, 22: 87-91.
  • 37. Wahn, V., W. Aberer, et al. Hereditary angioedema (HAE) in children and adolescents a consensus on therapeutic strategies. Eur J Pediatr. 2012.
  • 38. Wilkerson R.G [et al.].Angioedema in the emergency department: an evidence–based review. Emergency Medicine Practice. 2012, 14(11): 1-21.
  • 39. Zingale LC, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi B et al. Angioedema without urticaria: alarge clinical survey. CMAJ 2006, 175: 1065-1070.
  • 40. Zuberbier T, Asero R, Bindslev–Jensen C, Walter Canonica G, Church MK, Gimenez–Arnau A et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009, 64: 1417-1426. Поступила 3.12.2018 г.